Recently, the Arizona House Appropriations Committee approved HB2871 to spend up to $5 million for clinical research on an emerging plant medicine called ibogaine.
The bill has the backing of former U.S. Sen. Kyrsten Sinema, who has pledged to raise an additional $5 ...
Bill Supported by the Texas Ibogaine Initiative– a Coalition of Advocates, Experts, and Veterans Advancing Ibogaine Research
AUSTIN, Texas, March 5, 2025 /PRNewswire-PRWeb/ — Texas is once again proving its leadership in medical innovation with HB 3717, introduced by Rep. Cody Harris, to fund FDA-approved clinical trials of ibogaine—a potential breakthrough treatment for opioid use disorder, co-occurring substance use disorder, and other mental health ...
A short modular synthesis has been developed to produce the psychoactive substance ibogaine and related compounds.1 The approach could help to reduce dependency on natural plant sources for these products and generate new compounds with potential applications in the treatment of drug addiction and depression.
‘Anecdotal reports and some open-label clinical trials have suggested that ibogaine has profound anti-addictive and anti-depressant properties ...
Ibogaine by David Dardashti, a leading provider of ibogaine treatment for addiction, today announced a groundbreaking initiative that combines cutting-edge therapy with transformative travel experiences. The company is now offering clients the opportunity to participate in fully-funded therapeutic adventures to breathtaking destinations in Mexico, including Isla Mujeres, Cozumel, ...
The research would investigate ibogaine's potential to treat neurological disorders such as traumatic brain injuries and post-traumatic stress …